Investigate / reported ownership
HSIC
Henry Schein Inc
4 tracked reported owners · snapshot updated 2026-10-04. Delayed disclosures, not live holdings or an investment recommendation.
Who reports owning HSIC?
Select a manager to inspect their portfolio. Reports may cover different quarters; portfolio weights describe disclosed long 13F holdings, not total economic exposure.
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | 0.1% | 36q | $244M | 2,921,103 |
| 2 | Richard Pzena | 0.2% | 18q | $72M | 860,733 |
| 3 | Robert Olstein | 1.2% | 12q | $5M | 74,000 |
| 4 | Mason Hawkins | 0.1% | 8q | $1M | 17,038 |
Go beyond ownership.
Henry Schein distributes products and services to dental and medical markets, manufactures specialty health-care products and develops practice-management software.
Question to investigate: Can the company's broad single-source supply model keep customers and manage supplier dependence as the market consolidates?
Company research reviewed 2026-10-03; a dated source-linked starting point, not the investors’ stated reasons.
Understand the business and investment case →Filing dates and original SEC sources
Keep your next step small.
Save the company and inspect its evidence. Recording a private view is optional and requires a separate, explicit save.
Record my own view →Optional email follow
Latticework Follow
Follow HSIC
Email me only when a reviewed weekly edition contains a material new decision about HSIC: a new position, exit, or a large share-count change that also clears the size threshold. There may be quiet weeks.
Confirm by email. Manage or stop follows in one click. See our privacy notice.
Long US 13F disclosures omit shorts and can be amended. CUSIP 806407102. No current price, valuation or manager motive is inferred.